WPI

4 Pharmaceutical Stocks to Buy Now

This week, four pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More 

5 Pharmaceutical Stocks to Buy Now

The grades of five pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

8 Pharmaceutical Stocks to Buy Now

The grades of eight pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

8 Pharmaceutical Stocks to Buy Now

The grades of eight pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

3 Pharmaceutical Stocks to Buy Now

The grades of three pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

5 Pharmaceutical Stocks to Buy Now

The grades of five pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

ACT: Actavis’s Growth Potential Anything But Generic

Pharmaceutical company Actavis is at the forefront on the production of biologic drugs, and stands to profit from them well into the future. It's a buy! More